当前位置:首页 - 行情中心 - 宏源药业(301246) - 财务分析 - 资产负债表

宏源药业

(301246)

  

流通市值:26.49亿  总市值:65.84亿
流通股本:1.61亿   总股本:4.00亿

资产负债表

报告期2024-09-302024-06-302024-03-312023-12-31
公司类型通用通用通用通用
流动资产:
货币资金1,021,446,462.93763,824,133585,181,497.3421,862,807.47
应收票据及应收账款496,964,335.2495,337,798.53417,449,398.5381,954,346.87
其中:应收票据234,699,831.41211,648,145.31211,535,341.86171,380,626
应收账款262,264,503.79283,689,653.22205,914,056.64210,573,720.87
应收款项融资53,151,904.6136,963,084.69262,353,682.83220,681,896.81
预付款项38,122,99221,833,598.1331,007,323.4834,400,731.27
其他应收款合计81,055,950.9480,221,424.982,706,224.12141,667,251.87
应收股利---61,500,000
存货238,623,488.82234,191,630.23225,119,605.09191,506,412.04
其他流动资产421,543,360.99328,811,739.4940,088,322.35344,331,949.83
流动资产平衡项目0000
流动资产合计3,016,003,560.553,047,583,272.493,080,763,286.563,202,265,631.78
非流动资产:
长期股权投资205,708,779.46213,545,927.03221,378,828.22228,080,576.15
投资性房地产3,957,779.313,978,756.943,999,734.574,020,712.2
固定资产1,425,720,465.841,464,810,426.321,488,816,990.491,526,783,440.9
在建工程876,608,341.92791,302,319.06476,410,446.83375,858,582.74
使用权资产6,783,744.356,963,618.397,143,492.437,323,366.48
无形资产179,885,940.89181,046,940.25182,243,948.67183,058,812.4
长期待摊费用3,326,779.863,876,674.855,333,743.035,946,858.9
递延所得税资产15,902,624.7816,417,299.2316,072,028.9117,557,501.07
其他非流动资产122,760,946.71114,790,552.9158,100,727.399,875,308.72
非流动资产平衡项目0000
非流动资产合计2,840,655,403.122,796,732,514.972,559,499,940.452,448,505,159.56
资产平衡项目0000
资产总计5,856,658,963.675,844,315,787.465,640,263,227.015,650,770,791.34
流动负债:
短期借款55,401,696.727,337,181.33--
应付票据及应付账款841,896,769.5871,340,602.49629,016,628.84636,790,016.18
其中:应付票据352,476,784.89401,369,757.58388,199,235.62303,138,883.55
应付账款489,419,984.61469,970,844.91240,817,393.22333,651,132.63
合同负债21,867,225.5214,819,597.0414,871,513.7619,803,443.17
应付职工薪酬12,413,262.214,305,227.2513,262,114.6331,026,001.9
应交税费4,054,649.22,597,997.233,941,409.124,393,549.26
其他应付款合计46,211,687.871,800,429.9241,232,739.332,281,396.01
应付股利-19,900,340--
一年内到期的非流动负债68,928,604.9868,889,314.7465,554,00066,499,255.57
其他流动负债127,695,272.82110,689,914.31107,992,372.1124,034,583.55
流动负债平衡项目0000
流动负债合计1,178,469,168.741,161,780,264.31875,870,777.75914,828,245.64
非流动负债:
长期借款238,061,000240,838,000273,338,000276,115,000
租赁负债7,184,737.037,132,183.527,589,262.516,900,499.09
递延收益64,619,904.5166,891,783.6969,230,692.7771,552,258.08
递延所得税负债21,462,569.9321,346,375.321,724,174.6121,537,352.98
非流动负债平衡项目0000
非流动负债合计331,328,211.47336,208,342.51371,882,129.89376,105,110.15
负债平衡项目0000
负债合计1,509,797,380.211,497,988,606.821,247,752,907.641,290,933,355.79
所有者权益(或股东权益):
实收资本(或股本)400,006,800400,006,800400,006,800400,006,800
资本公积2,172,141,087.072,172,082,219.762,171,773,705.552,171,725,787.1
减:库存股31,405,166.1431,157,176.11--
专项储备3,659,149.783,268,258.863,312,944.761,887,041.01
盈余公积185,239,736.88185,239,736.88185,239,736.88185,239,736.88
未分配利润1,617,219,975.871,616,887,341.251,632,177,132.181,600,978,070.56
归属于母公司股东权益平衡项目0000
归属于母公司股东权益合计4,346,861,583.464,346,327,180.644,392,510,319.374,359,837,435.55
股东权益平衡项目0000
股东权益合计4,346,861,583.464,346,327,180.644,392,510,319.374,359,837,435.55
负债和股东权益合计5,856,658,963.675,844,315,787.465,640,263,227.015,650,770,791.34
公告日期2024-10-252024-08-302024-04-232024-04-23
审计意见(境内)标准无保留意见
TOP↑